CELU Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-13 | Fletcher Kyle | officer: See Remarks | 21,085 | F-InKind | D | 20 | 4.11 | 82.20 |
| 2024-04-13 | Haines John R | officer: See Remarks | 38,373 | F-InKind | D | 576 | 4.11 | 2,367.00 |
| 2024-04-13 | Beers David C | officer: Chief Financial Officer | 23,983 | F-InKind | D | 360 | 4.11 | 1,480.00 |
| 2024-04-13 | Hariri Robert J | officer: Chief Executive Officer | 2,855,889 | F-InKind | D | 1,154 | 4.11 | 4,743.00 |
| 2024-04-13 | Brigido Stephen | officer: Pres, Functional Regeneration | 19,472 | F-InKind | D | 268 | 4.11 | 1,101.00 |
| 2024-03-15 | Fletcher Kyle | officer: See Remarks | 21,105 | F-InKind | D | 617 | 5.68 | 3,505.00 |
| 2024-03-13 | Lim Kok Thay | 10 percent owner | 300,000 | J-Other | A | 300,000 | 5.90 | 1,768,500.00 |
| 2024-02-16 | Hariri Robert J | director, officer: Chief Executive Officer | 2,937,788 | A-Award | A | 2,937,788 | 0.43 | 1,275,000.00 |
| 2024-02-17 | Kilcoyne Adrian | officer: Chief Medical Officer | 1,122,238 | F-InKind | D | 52,762 | 0.43 | 22,899.00 |
| 2024-02-16 | Kilcoyne Adrian | officer: Chief Medical Officer | 205,213 | A-Award | A | 205,213 | 0.43 | 89,062.00 |
| 2024-02-17 | Haines John R | officer: See Remarks | 389,497 | F-InKind | D | 70,350 | 0.43 | 30,532.00 |
| 2024-02-16 | Haines John R | officer: See Remarks | 216,014 | A-Award | A | 216,014 | 0.43 | 93,750.00 |
| 2024-02-17 | Beers David C | officer: Chief Financial Officer | 243,437 | F-InKind | D | 43,968 | 0.43 | 19,082.00 |
| 2024-02-16 | Beers David C | officer: Chief Financial Officer | 183,612 | A-Award | A | 183,612 | 0.43 | 79,688.00 |
| 2024-02-17 | Brigido Stephen | officer: Pres, Functional Regeneration | 197,406 | F-InKind | D | 32,720 | 0.43 | 14,200.00 |
| 2024-02-16 | Brigido Stephen | officer: Pres, Functional Regeneration | 183,612 | A-Award | A | 183,612 | 0.43 | 79,688.00 |
| 2024-02-17 | Fletcher Kyle | officer: See Remarks | 217,228 | F-InKind | D | 39,571 | 0.43 | 17,174.00 |
| 2024-02-16 | Fletcher Kyle | officer: See Remarks | 164,171 | A-Award | A | 164,171 | 0.43 | 71,250.00 |
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 51,473,762 | P-Purchase | A | 21,410,983 | 0.25 | 5,331,335.00 |
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 16,500,000 | P-Purchase | A | 16,500,000 | 0.25 | 4,108,500.00 |
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 6,529,818 | J-Other | A | 6,529,818 | 0.25 | 1,625,925.00 |
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 5,352,746 | P-Purchase | A | 5,352,746 | 0.25 | 1,332,834.00 |
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 0 | J-Other | D | 6,529,818 | 6.77 | 44,206,868.00 |
| 2023-08-31 | Ling Geoffrey M.D. | director | 1,250,000 | A-Award | A | 1,250,000 | 0.32 | 405,000.00 |
| 2023-08-31 | Ling Geoffrey M.D. | 0 | 0 | 0.00 | 0.00 | |||
| 2023-10-05 | Hariri Robert J | director, officer: Chief Executive Officer | 28,570,434 | P-Purchase | A | 3,050,427 | 0.16 | 483,798.00 |
| 2023-10-05 | Hariri Robert J | director, officer: Chief Executive Officer | 25,520,007 | P-Purchase | A | 6,307,158 | 0.16 | 1,000,315.00 |
| 2023-09-29 | Hariri Robert J | director, officer: Chief Executive Officer | 19,212,849 | P-Purchase | A | 9,064,539 | 0.17 | 1,500,181.00 |
| 2023-09-29 | Sorrento Therapeutics, Inc. | 10 percent owner | 11,357,585 | S-Sale | D | 9,064,539 | 1.50 | 13,596,808.00 |
| 2023-10-05 | Sorrento Therapeutics, Inc. | 10 percent owner | 5,050,427 | S-Sale | D | 6,307,158 | 1.50 | 9,460,737.00 |
| 2023-07-14 | Kilcoyne Adrian | officer: Chief Medical Officer | 1,175,000 | A-Award | A | 875,000 | 0.00 | 0.00 |
| 2023-06-14 | Lim Kok Thay | director | 225,222 | F-InKind | D | 10,844 | 0.75 | 8,136.00 |
| 2023-06-20 | Genting Berhad | 10 percent owner | 3,000,000 | P-Purchase | A | 3,000,000 | 0.81 | 2,430,000.00 |
| 2023-06-14 | Parks Diane L. | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Parks Diane L. | director | 236,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | Kehler Dean C | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Kehler Dean C | director | 236,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | Smith Robin L | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Smith Robin L | director | 236,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | Mazur Marc | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Mazur Marc | director | 236,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | VON ESCHENBACH ANDREW C. | director | 336,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | VON ESCHENBACH ANDREW C. | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | SCULLEY JOHN | director | 1,004,660 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | SCULLEY JOHN | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Diamandis Peter | director | 1,307,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-06-14 | Diamandis Peter | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Lim Kok Thay | director | 277,778 | A-Award | A | 277,778 | 0.75 | 208,417.00 |
| 2023-06-14 | Lim Kok Thay | director | 236,066 | A-Award | A | 199,921 | 0.00 | 0.00 |
| 2023-04-13 | Brigido Stephen | officer: Pres, Functional Regeneration | 230,126 | F-InKind | D | 2,683 | 0.71 | 1,916.00 |
| 2023-04-13 | Fletcher Kyle | officer: See Remarks | 256,799 | F-InKind | D | 201 | 0.71 | 143.50 |
| 2023-04-13 | Hariri Robert J | director, officer: Chief Executive Officer | 10,148,310 | F-InKind | D | 11,540 | 0.71 | 8,241.00 |
| 2023-04-13 | Beers David C | officer: Chief Financial Officer | 287,405 | F-InKind | D | 3,606 | 0.71 | 2,575.00 |
| 2023-04-13 | Haines John R | officer: See Remarks | 459,847 | F-InKind | D | 5,770 | 0.71 | 4,120.00 |
| 2023-04-13 | Glover Bradley | officer: See Remarks | 351,192 | F-InKind | D | 2,884 | 0.71 | 2,059.00 |
| 2023-03-15 | Fletcher Kyle | officer: See Remarks | 257,000 | F-InKind | D | 2,170 | 0.63 | 1,365.00 |
| 2023-03-27 | Hariri Robert J | director, officer: Chief Executive Officer | 10,159,850 | A-Award | A | 2,084,854 | 0.83 | 1,739,394.00 |
| 2023-03-27 | Hariri Robert J | director, officer: Chief Executive Officer | 2,084,854 | A-Award | D | 2,084,854 | 3.00 | 6,254,562.00 |
| 2023-02-17 | Fletcher Kyle | officer: See Remarks | 259,170 | A-Award | A | 225,000 | 0.00 | 0.00 |
| 2023-02-17 | Haines John R | officer: Senior Exec Vice President | 465,617 | A-Award | A | 400,000 | 0.00 | 0.00 |
| 2023-02-17 | Beers David C | officer: Chief Financial Officer | 291,011 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2023-02-17 | Glover Bradley | officer: See Remarks | 354,076 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2023-02-17 | Brigido Stephen | officer: Pres, Functional Regeneration | 232,809 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-02-17 | Kilcoyne Adrian | officer: Chief Medical Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2023-02-10 | Diamandis Peter | director | 2,660,136 | M-Exempt | D | 1,071,000 | 0.28 | 299,880.00 |
| 2023-02-10 | Diamandis Peter | director | 1,107,145 | M-Exempt | A | 1,071,000 | 0.28 | 299,880.00 |
| 2022-11-30 | Hariri Robert J | officer: Chief Executive Officer | 8,074,996 | P-Purchase | A | 10,000 | 1.72 | 17,175.00 |
| 2022-11-29 | Hariri Robert J | officer: Chief Executive Officer | 8,064,996 | P-Purchase | A | 40,000 | 1.71 | 68,400.00 |
| 2022-11-28 | Hariri Robert J | officer: Chief Executive Officer | 8,024,996 | P-Purchase | A | 40,000 | 1.74 | 69,600.00 |
| 2021-11-16 | Jones Anne | officer: Chief Business Officer | 52,888 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2022-11-16 | Jones Anne | officer: Chief Business Officer | 49,154 | F-InKind | D | 3,734 | 1.89 | 7,057.00 |
| 2022-11-16 | Fletcher Kyle | officer: General Counsel | 34,170 | F-InKind | D | 1,262 | 1.89 | 2,385.00 |
| 2021-11-16 | Glover Bradley | officer: See Remarks | 57,810 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-11-16 | Glover Bradley | officer: See Remarks | 54,076 | F-InKind | D | 3,734 | 1.89 | 7,057.00 |
| 2022-10-03 | Kilcoyne Adrian | officer: See Remarks | 66,226 | A-Award | A | 66,226 | 0.00 | 0.00 |
| 2022-09-29 | Kilcoyne Adrian | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-08-26 | SCULLEY JOHN | director: | 804,739 | M-Exempt | A | 768,594 | 0.28 | 215,206.00 |
| 2022-08-26 | SCULLEY JOHN | director | 0 | M-Exempt | D | 768,594 | 0.28 | 215,206.00 |
| 2022-08-24 | Hariri Robert J | director, officer: Chief Executive Officer | 7,984,996 | M-Exempt | A | 119,073 | 2.87 | 341,740.00 |
| 2022-08-24 | Hariri Robert J | director, officer: Chief Executive Officer | 230,287 | M-Exempt | D | 119,073 | 2.87 | 341,740.00 |
| 2022-08-24 | Hariri Robert J | officer: Chief Executive Officer | 230,287 | M-Exempt | D | 119,073 | 0.00 | 0.00 |
| 2022-08-16 | Smith Robin L | director | 800,000 | A-Award | A | 800,000 | 2.99 | 2,392,000.00 |
| 2022-08-16 | Smith Robin L | director | 250,000 | A-Award | A | 250,000 | 2.99 | 747,500.00 |
| 2022-08-16 | Smith Robin L | director: | 250,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2022-07-13 | Diamandis Peter | director | 54,152 | A-Award | A | 54,152 | 4.15 | 224,731.00 |
| 2022-07-13 | Diamandis Peter | director: | 54,152 | A-Award | A | 54,152 | 0.00 | 0.00 |
| 2022-07-13 | Diamandis Peter | director | 36,145 | A-Award | A | 36,145 | 0.00 | 0.00 |
| 2022-07-13 | SCULLEY JOHN | director: | 54,152 | A-Award | A | 54,152 | 0.00 | 0.00 |
| 2022-07-13 | SCULLEY JOHN | director | 54,152 | A-Award | A | 54,152 | 4.15 | 224,731.00 |
| 2022-07-13 | SCULLEY JOHN | director | 36,145 | A-Award | A | 36,145 | 0.00 | 0.00 |
| 2022-07-13 | Lim Kok Thay | director: | 54,152 | A-Award | A | 54,152 | 0.00 | 0.00 |
| 2022-07-13 | Kehler Dean C | director: | 54,152 | A-Award | A | 54,152 | 0.00 | 0.00 |
| 2022-07-13 | Kehler Dean C | director | 54,152 | A-Award | A | 54,152 | 4.15 | 224,731.00 |
| 2022-07-13 | Kehler Dean C | director | 36,145 | A-Award | A | 36,145 | 0.00 | 0.00 |
| 2022-07-13 | Glover Bradley | officer: Chief Technology Officer | 32,810 | A-Award | A | 13,124 | 0.00 | 0.00 |
| 2022-07-13 | Mazur Marc | director: | 36,145 | A-Award | A | 36,145 | 0.00 | 0.00 |
| 2022-07-13 | Parks Diane L. | director: | 54,152 | A-Award | A | 54,152 | 0.00 | 0.00 |
| 2022-07-13 | Jones Anne | officer: Chief Business Officer | 33,670 | A-Award | A | 33,670 | 0.00 | 0.00 |
| 2022-07-13 | Fletcher Kyle | officer: General Counsel | 6,735 | A-Award | A | 6,735 | 0.00 | 0.00 |
| 2022-07-13 | Smith Robin L | director | 54,152 | A-Award | A | 54,152 | 4.15 | 224,731.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
